{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:32:53Z","timestamp":1776763973914,"version":"3.51.2"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ygyno.2016.08.231","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T13:59:08Z","timestamp":1471701548000},"page":"326-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing"],"prefix":"10.1016","volume":"143","author":[{"given":"Kine","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivar S.","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2016.08.231_bb0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers - a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.ygyno.2016.08.231_bb0010","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis."},{"issue":"9590","key":"10.1016\/j.ygyno.2016.08.231_bb0015","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0020","series-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100B","author":"International Agency for Research on Cancer","year":"2012"},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2016.08.231_bb0025","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0030","series-title":"HPV Primary Screening Pilot Announced","author":"NHS Cervical Screening Programme","year":"2012"},{"issue":"2","key":"10.1016\/j.ygyno.2016.08.231_bb0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ijc.29381","article-title":"Primary human papillomavirus DNA screening for cervical cancer prevention: can the screening interval be safely extended?","volume":"137","author":"Vink","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0040","series-title":"HPV testing in primary cervical cancer screening","author":"Nygard","year":"2013"},{"issue":"1","key":"10.1016\/j.ygyno.2016.08.231_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003460","article-title":"Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme","volume":"4","author":"Nygard","year":"2014","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ygyno.2016.08.231_bb0050","doi-asserted-by":"crossref","first-page":"356.e1","DOI":"10.1016\/j.ajog.2007.07.049","article-title":"Risk assessment to guide the prevention of cervical cancer","volume":"197","author":"Castle","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2016.08.231_bb0055","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2303.2008.00623.x","article-title":"European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1","volume":"19","author":"Jordan","year":"2008","journal-title":"Cytopathology"},{"issue":"5 Suppl 1","key":"10.1016\/j.ygyno.2016.08.231_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"3","key":"10.1016\/j.ygyno.2016.08.231_bb0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition\u2013summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.08.231_bb0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JCM.02116-14","article-title":"A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results","volume":"53","author":"Schiffman","year":"2015","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"10.1016\/j.ygyno.2016.08.231_bb0075","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/bjc.2012.94","article-title":"Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway","volume":"106","author":"Burger","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2016.08.231_bb0080","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jval.2015.08.003","article-title":"Using decision-analytic modeling to isolate interventions that are feasible, efficient and optimal: an application from the Norwegian cervical cancer screening program","volume":"18","author":"Pedersen","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0085","article-title":"Using novel biomarkers to triage young adult women with minor cervical lesions: a cost-effectiveness analysis","author":"Pedersen","year":"2016","journal-title":"BJOG: An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12885-015-1332-8","article-title":"Systematic review of model-based cervical screening evaluations","volume":"15","author":"Mendes","year":"2015","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.ygyno.2016.08.231_bb0095","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1001\/jama.287.18.2382","article-title":"Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance","volume":"287","author":"Kim","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ygyno.2016.08.231_bb0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/aje\/kwu159","article-title":"An updated natural history model of cervical cancer: derivation of model parameters","volume":"180","author":"Campos","year":"2014","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.08.231_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/aje\/kwm086","article-title":"Multiparameter calibration of a natural history model of cervical cancer","volume":"166","author":"Kim","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2016.08.231_bb0110","series-title":"Average rates of exchange","author":"Federal Reserve","year":"2014"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0115","series-title":"Economic evaluation of health interventions - A guide","author":"Norwegian Directorate of Health","year":"2012"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0120","series-title":"Health Effects of Socio-economic Analyses","author":"Norwegian Directorate of Health","year":"2007"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0125","author":"Statistics Norway","year":"2015"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0130","unstructured":"Technical Appendix. Harvard Cervical Cancer Natural History Model: Calibration and Costing Approach for Norway. Accessed at: http:\/\/www.med.uio.no\/helsam\/english\/research\/projects\/preventive-strategies-hpv\/harvardmodel-norway-technicalappendix.pdf on July 28, 2016."},{"key":"10.1016\/j.ygyno.2016.08.231_bb0135","series-title":"Annual Report of the Norwegian Cervical Cancer Screening Program, 2013\u201314","author":"Cancer Registry of Norway","year":"2015"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0140","series-title":"Risk of Cervical Cancer by Screening Intensity: A Registry-based Analysis","author":"Pedersen","year":"2015"},{"issue":"16","key":"10.1016\/j.ygyno.2016.08.231_bb0145","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9916","key":"10.1016\/j.ygyno.2016.08.231_bb0150","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ygyno.2016.08.231_bb0155","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2016.08.231_bb0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2016.08.231_bb0165","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000381","article-title":"The interpretive variability of cervical biopsies and its relationship to HPV status","volume":"39","author":"Stoler","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.08.231_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/14737159.2015.961915","article-title":"Role of E6\/E7 mRNA test in the diagnostic algorithm of HPV-positive patients showing ASCUS and LSIL: clinical and economic implications in a publicly financed healthcare system","volume":"15","author":"Zappacosta","year":"2015","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"6","key":"10.1016\/j.ygyno.2016.08.231_bb0175","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jval.2012.06.012","article-title":"Modeling good research practices\u2013overview: a report of the ISPOR-SMDM modeling good research practices task force\u20131","volume":"15","author":"Caro","year":"2012","journal-title":"Value in Health"},{"issue":"3","key":"10.1016\/j.ygyno.2016.08.231_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089974","article-title":"Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys","volume":"9","author":"Burger","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2016.08.231_bb0185","series-title":"Patient preferences for health states related to HPV infection: visual analygue scales versus time trade-off eliciation [abstract]","author":"Myers","year":"2004"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816312549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816312549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T00:51:22Z","timestamp":1536454282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816312549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0090825816312549"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.08.231","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.08.231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}